Carregant...
Managing Pulmonary Toxicities Associated with Immunotherapy: A Case Discussion
Immunotherapy has changed the field of oncology around the world with the approval of immune checkpoint inhibitors for a number of tumor types over the last 5 years. However, immune‐mediated adverse events can be challenging and difficult to treat, with one of the most dire consequences being immune...
Guardat en:
| Publicat a: | Oncologist |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656522/ https://ncbi.nlm.nih.gov/pubmed/30898888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0241 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|